Literature DB >> 15578034

Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND).

Steven M Shapiro1.   

Abstract

Kernicterus, currently used to describe both the neuropathology of bilirubin-induced brain injury and its associated clinical findings, is a complex syndrome. The neurobiology of kernicterus, including the determinants and mechanisms of neuronal injury, is discussed along with traditional and evolving definitions ranging from classical kernicterus with athetoid cerebral palsy, impaired upward gaze and deafness, to isolated conditions, for example, auditory neuropathy or dys-synchrony (AN/AD), and subtle bilirubin-induced neurological dysfunction (BIND). The clinical expression of BIND varies with location, severity, and time of assessment, influenced by the amount, duration and developmental age of exposure to excessive free bilirubin. Although total serum bilirubin (TSB) is important, kernicterus cannot be defined based solely on TSB. For study purposes kernicterus may be defined in term and near-term infants with TSB > or = 20 mg/dl using abnormal muscle tone on examination, auditory testing diagnostic of AN/AD, and magnetic resonance imaging showing bilateral lesions of globus pallidus+/-subthalamic nucleus.

Entities:  

Mesh:

Year:  2005        PMID: 15578034     DOI: 10.1038/sj.jp.7211157

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  66 in total

1.  Profile of minocycline neuroprotection in bilirubin-induced auditory system dysfunction.

Authors:  Ann C Rice; Victoria L Chiou; Sarah B Zuckoff; Steven M Shapiro
Journal:  Brain Res       Date:  2010-11-12       Impact factor: 3.252

2.  Fate of Neural Progenitor Cells Transplanted Into Jaundiced and Nonjaundiced Rat Brains.

Authors:  Fu-Chen Yang; Sean M Riordan; Michelle Winter; Li Gan; Peter G Smith; Jay L Vivian; Steven M Shapiro; John A Stanford
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

Review 3.  Sensory integration, sensory processing, and sensory modulation disorders: putative functional neuroanatomic underpinnings.

Authors:  Leonard F Koziol; Deborah Ely Budding; Dana Chidekel
Journal:  Cerebellum       Date:  2011-12       Impact factor: 3.847

4.  Reduced Myelination and Increased Glia Reactivity Resulting from Severe Neonatal Hyperbilirubinemia.

Authors:  Andreia Barateiro; Shujuan Chen; Mei-Fei Yueh; Adelaide Fernandes; Helena Sofia Domingues; João Relvas; Olivier Barbier; Nghia Nguyen; Robert H Tukey; Dora Brites
Journal:  Mol Pharmacol       Date:  2015-10-19       Impact factor: 4.436

5.  Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-κB leads to hyperbilirubinemia.

Authors:  Ryoichi Fujiwara; Shujuan Chen; Michael Karin; Robert H Tukey
Journal:  Gastroenterology       Date:  2011-10-06       Impact factor: 22.682

6.  Effect of Hyperbilirubinemia on Medial Olivocochlear System in Newborns.

Authors:  Burak Karabulut; Mehmet Sürmeli; Şenol Bozdağ; İldem Deveci; Rıza Doğan; Çağatay Oysu
Journal:  J Int Adv Otol       Date:  2019-08       Impact factor: 1.017

7.  Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy.

Authors:  Trinity Vera; Ralph B D'Agostino; Jennifer H Jordan; Matthew C Whitlock; Giselle C Meléndez; Zanetta S Lamar; Mercedes Porosnicu; Herbert L Bonkovsky; Leslie B Poole; W Gregory Hundley
Journal:  Am J Cardiol       Date:  2015-09-10       Impact factor: 2.778

8.  Relationship between behavioral hearing thresholds and estimated auditory steady-state response thresholds in children with a history of neonatal hyperbilirubinemia.

Authors:  Rasool Panahi; Zahra Jafari; Sara Hasani
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-06       Impact factor: 2.503

9.  Pedaudiologic findings after severe neonatal hyperbilirubinemia.

Authors:  Andreas Nickisch; Claudia Massinger; Birgit Ertl-Wagner; Hubertus von Voss
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-17       Impact factor: 2.503

10.  Cadmium and arsenic override NF-κB developmental regulation of the intestinal UGT1A1 gene and control of hyperbilirubinemia.

Authors:  Miao Liu; Shujuan Chen; Mei-Fei Yueh; Ryoichi Fujiwara; Camille Konopnicki; Haiping Hao; Robert H Tukey
Journal:  Biochem Pharmacol       Date:  2016-04-06       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.